Quantus

SEC FORM 13F

안드레아스 할보르센

Viking Global Investors

Andreas Halvorsen

공시 기준일
2026-03-31
표시 종목
64 / 77
13F 평가액
$35.7B

이번 분기 하이라이트 (2026-03-31 공시)

신규 매수15

Apple, Fedex, Meta Platforms Class A …

추가 매수22

Visa Class A, Charles Schwab, Walt Disney …

축소19

Taiwan Semiconductor Manufacturing, Air Products and Chemicals, Sherwin Williams …

보유 종목

비중 높은 순

  1. 1
    Visa Class A5.8%
    V-US · $1.9B추가+2,343,980주
  2. 2
    Taiwan Semiconductor Manufacturing4.6%
    TSM-US · $1.5B축소-449,769주
  3. 3
    Charles Schwab4.2%
    SCHW-US · $1.4B추가+792,049주
  4. 4
    Walt Disney3.9%
    DIS-US · $1.3B추가+2,104,958주
  5. 5
    Fortive3.8%
    FTV-US · $1.2B추가+3,251,123주
  6. 6
    Air Products and Chemicals3.6%
    APD-US · $1.2B축소-678,439주
  7. 7
    McDonald`s3.4%
    MCD-US · $1.1B추가+5,814주
  8. 8
    Sherwin Williams3%
    SHW-US · $997.8M축소-59,541주
  9. 9
    Tesla2.8%
    TSLA-US · $927M추가+793,820주
  10. 10
    Apple2.8%
    AAPL-US · $911.9M신규
  11. 11
    BridgeBio Pharma2.7%
    BBIO-US · $879.4M축소-2,551,500주
  12. 12
    Carvana Class A2.6%
    CVNA-US · $874M추가+1,718,502주
  13. 13
    Microsoft2.6%
    MSFT-US · $854.9M축소-908,196주
  14. 14
    Thermo Fisher Scientific2.5%
    TMO-US · $819.9M추가+874,838주
  15. 15
    JPMorgan Chase2.4%
    JPM-US · $795.4M추가+798,036주
  16. 16
    CSX2.3%
    CSX-US · $766.7M추가+4,860,513주
  17. 17
    Intercontinental Exchange2.3%
    ICE-US · $760.7M추가+33,699주
  18. 18
    Lennox International2.2%
    LII-US · $729.8M추가+951,108주
  19. 19
    Alphabet Class A2.1%
    GOOGL-US · $689M축소-270,407주
  20. 20
    Fedex2.1%
    FDX-US · $688.2M신규
  21. 21
    General Motors2.1%
    GM-US · $683.7M추가+2,370,848주
  22. 22
    Boeing1.9%
    BA-US · $636.1M축소-757,046주
  23. 23
    PNC Financial Services Group1.9%
    PNC-US · $629.9M축소-4,259,976주
  24. 24
    T Mobile US1.9%
    TMUS-US · $623.2M축소-786,844주
  25. 25
    Meta Platforms Class A1.8%
    META-US · $607.9M신규
  26. 26
    Regal Rexnord1.8%
    RRX-US · $588.5M축소-81,089주
  27. 27
    Mid America Apartment Communities REIT1.8%
    MAA-US · $586M추가+918,356주
  28. 28
    Medline Inc. Class A Common Stock1.5%
    MDLN-US · $508.8M추가+4,474,835주
  29. 29
    HCA Healthcare1.5%
    HCA-US · $508.8M추가+75,953주
  30. 30
    ATI1.5%
    ATI-US · $484.8M신규
  31. 31
    Celestica1.4%
    CLS-US · $466.2M축소-44,247주
  32. 32
    Camden Property Trust REIT1.4%
    CPT-US · $460.5M축소-49,101주
  33. 33
    Adaptive Biotechnologies1.3%
    ADPT-US · $416.3M유지
  34. 34
    BioMarin Pharmaceutical1.2%
    BMRN-US · $398.9M추가+1,025,141주
  35. 35
    Waters1.1%
    WAT-US · $374.2M신규
  36. 36
    Carnival1.1%
    CCL-US · $355.1M축소-340,479주
  37. 37
    Aon Class A1.1%
    AON-US · $350.9M추가+303,464주
  38. 38
    Hasbro1.1%
    HAS-US · $350M신규
  39. 39
    Progressive1%
    PGR-US · $320.5M추가+285,021주
  40. 40
    American International Group1%
    AIG-US · $317.6M신규
  41. 41
    Capital One Financial0.9%
    COF-US · $294.1M축소-1,339,943주
  42. 42
    Dicks Sporting0.8%
    DKS-US · $250.7M축소-1,308,799주
  43. 43
    Amazon Com0.8%
    AMZN-US · $249M축소-1,931,388주
  44. 44
    APi Group0.7%
    APG-US · $236.5M축소-5,700,518주
  45. 45
    Acuren Corporation0.7%
    TIC-US · $235.7M추가+1,464,562주
  46. 46
    Cboe Global Markets0.6%
    CBOE-US · $193.5M신규
  47. 47
    Roivant Sciences0.6%
    ROIV-US · $184.3M추가+209,257주
  48. 48
    Home Depot0.5%
    HD-US · $165.8M신규
  49. 49
    Arthur J Gallagher0.5%
    AJG-US · $157.5M축소-313,536주
  50. 50
    lululemon athletica0.5%
    LULU-US · $150.1M신규
  51. 51
    Sionna Therapeutics, Inc. Common Stock0.4%
    SION-US · $128.1M유지
  52. 52
    CoreWeave, Inc. Class A Common Stock0.3%
    CRWV-US · $108.3M신규
  53. 53
    West Pharmaceutical Services0.3%
    WST-US · $104.5M추가+121,920주
  54. 54
    Pharvaris N V0.3%
    PHVS-US · $103.2M유지
  55. 55
    Inhibrx0.3%
    INBX-US · $96.7M유지
  56. 56
    Interactive Brokers Group Class A0.3%
    IBKR-US · $93.5M신규
  57. 57
    Edwards Lifesciences0.3%
    EW-US · $87.9M신규
  58. 58
    ORIC Pharmaceuticals0.2%
    ORIC-US · $73.8M축소-748,158주
  59. 59
    Twilio Class A0.2%
    TWLO-US · $56.7M신규
  60. 60
    Standard BioTools0.2%
    LAB-US · $53.9M유지
  61. 61
    Trevi Therapeutics0.1%
    TRVI-US · $38.2M유지
  62. 62
    Ginkgo Bioworks Holdings Class A0.1%
    DNA-US · $21.9M유지
  63. 63
    PepGen0%
    PEPG-US · $6.2M유지
  64. 64
    Rallybio0%
    RLYB-US · $4.7M신규

사실 정보이며 투자 조언이 아닙니다.